A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 1/2 Terminated
2 enrolled
SYS-CAPLIOX
Phase 1/2 Terminated
5 enrolled
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
6 enrolled 15 charts
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Phase 1/2 Terminated
2 enrolled 13 charts
MODULATE
Phase 1/2 Terminated
2 enrolled 7 charts
QUILT-3.080: NANT Pancreatic Cancer Vaccine
Phase 1/2 Terminated
3 enrolled 13 charts
QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
Phase 1/2 Terminated
9 enrolled 18 charts
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
Phase 1/2 Terminated
4 enrolled 14 charts
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
3 enrolled 9 charts
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
4 enrolled 9 charts
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
Phase 1/2 Terminated
8 enrolled 14 charts
A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
Phase 1/2 Terminated
2 enrolled 9 charts
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer
Phase 1/2 Terminated
32 enrolled
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Phase 1/2 Terminated
32 enrolled 18 charts
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
Phase 1/2 Terminated
4 enrolled
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Phase 1/2 Terminated
16 enrolled 15 charts
Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
Phase 1/2 Terminated
44 enrolled 6 charts
NivoPlus
Phase 1/2 Terminated
33 enrolled
Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer
Phase 1/2 Terminated
10 enrolled 2 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
Phase 1/2 Terminated
7 enrolled 8 charts
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
Phase 1/2 Terminated
57 enrolled 11 charts
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
Phase 1/2 Terminated
72 enrolled 15 charts
AMOR
Phase 1/2 Terminated
4 enrolled 7 charts
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
Phase 1/2 Terminated
50 enrolled
A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer
Phase 1/2 Terminated
39 enrolled
Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Phase 1/2 Terminated
21 enrolled
IXO+A
Phase 1/2 Terminated
23 enrolled
Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
Phase 1/2 Terminated
32 enrolled 15 charts
Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
Phase 1/2 Terminated
10 enrolled
Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer
Phase 1/2 Terminated
1 enrolled